LONDON–(BUSINESS WIRE)–#MultiplexedDiagnosticsMarket–Technavio has been monitoring the multiplexed diagnostics market and it is poised to grow by USD 9.35 billion during 2020-2024, progressing at a CAGR of over 15% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Free Sample Report on COVID-19 Impact
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Agilent Technologies Inc., Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Merck KGaA, QIAGEN NV, F. Hoffmann-La Roche Ltd., Siemens AG, and Thermo Fisher Scientific Inc. are some of the major market participants. The prevalence of chronic and infectious diseases will offer immense growth opportunities. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The prevalence of chronic and infectious diseases has been instrumental in driving the growth of the market.
Multiplexed Diagnostics Market 2020-2024: Segmentation
Multiplexed Diagnostics Market is segmented as below:
-
End-user
- Pharmaceutical And Biotechnology Companies
- Healthcare Centers
- Academic Institutes And CROs
-
Geographic Landscape
- APAC
- Europe
- MEA
- North America
- South America
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40652
Multiplexed Diagnostics Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our multiplexed diagnostics market report covers the following areas:
- Multiplexed Diagnostics Market size
- Multiplexed Diagnostics Market trends
- Multiplexed Diagnostics Market industry analysis
This study identifies technological advancements as one of the prime reasons driving the multiplexed diagnostics market growth during the next few years.
Multiplexed Diagnostics Market 2020-2024: Vendor Analysis
We provide a detailed analysis of vendors operating in the multiplexed diagnostics market, including some of the vendors such as Agilent Technologies Inc., Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Merck KGaA, QIAGEN NV, F. Hoffmann-La Roche Ltd., Siemens AG, and Thermo Fisher Scientific Inc. Backed with competitive intelligence and benchmarking, our research reports on the multiplexed diagnostics market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Multiplexed Diagnostics Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist multiplexed diagnostics market growth during the next five years
- Estimation of the multiplexed diagnostics market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the multiplexed diagnostics market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of multiplexed diagnostics market vendors
Table Of Contents:
Executive Summary
- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by End-user
- Market segments
- Comparison by End user placement
- Pharmaceutical and biotechnology companies – Market size and forecast 2019-2024
- Healthcare centers – Market size and forecast 2019-2024
- Academic institutes and CROs – Market size and forecast 2019-2024
- Market opportunity by End user
Customer Landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America – Market size and forecast 2019-2024
- Europe – Market size and forecast 2019-2024
- APAC – Market size and forecast 2019-2024
- South America – Market size and forecast 2019-2024
- MEA – Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
Drivers, Challenges, and Trends
- Market drivers
- Volume driver – Demand led growth
- Volume driver – Supply led growth
- Volume driver – External factors
- Volume driver – Demand shift in adjacent markets
- Price driver – Inflation
- Price driver – Shift from lower to higher priced units
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Agilent Technologies Inc.
- Becton, Dickinson and Co.
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Merck KGaA
- QIAGEN NV
- F. Hoffmann-La Roche Ltd.
- Siemens AG
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/